Safety of OKT3 use in the operating room.
Shield
C F
CF
Transplantation Service, St Francis Regional Medical Center, Wichita, Kansas.
Beilman
G
G
D002102:Cadaver; D006085:Graft Survival; D006801:Humans; D007432:Intraoperative Period; D016030:Kidney Transplantation / Q000401:mortality / Q000502:physiology*; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D016019:Survival Analysis; D014019:Tissue Donors; D014184:Transplantation, Homologous
D016853:Muromonab-CD3